You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Thousands of blood cancer patients could benefit from new drug combination
- 2. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 3. Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- 4. Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
- 5. Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
- 6. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 7. Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
- 8. Effects of gut microbiota in breast cancer
- 9. Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
- 10. Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal
Last updated at 17:31 GMT
Hot News Makers
Health/Pharma Companies
-
55546.92
-
31028.32
-
28374.61
-
26958.61
-
25283.73
-
18200.92
-
14896.98
-
14632.15
-
14581.05
-
10316.42
Drugs, Treatments, Trials
-
23003.51
-
15119.20
-
9093.38
-
8613.41
-
7763.11
-
6872.36
-
6473.46
-
5462.93
-
3910.34
-
3707.89
Last updated at 17:10 GMT
